Zosuquidar(3HCl)
-
Molecular Structure
Detailed Description
Zosuquidar is an experimental antineoplastic drug currently under development. It has completed Phase 3 clinical trials in the United States. It inhibits P-glycoproteins. Other drugs with this mechanism include tariquidar and laniquidar.
- Zosuquidar(3HCl)